根据美国证券交易委员会（SEC）最新披露的文件，Amphastar Pharmaceuticals Inc（安法斯特制药）已签订一项具有五年效力的供应协议，且协议项下所有款项均将以人民币进行结算。
该协议不仅凸显了双方长期合作的稳固意向，更反映出跨境贸易中人民币结算方式的应用正逐步扩大。以本币直接结算有助于企业规避汇率波动风险，并可能提升交易效率。
此次为期五年的合作框架，为Amphastar Pharmaceuticals未来的营收稳定性提供了可见性，同时也展现了公司在国际业务布局上的战略考量。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.